1YR企业会员
| 英文名称 | 中文名称 | CAS |
|---|---|---|
| MG-115 | MG115,蛋白酶体抑制剂 | 133407-86-0 |
| Octanal | 正辛醛 | 124-13-0 |
| PF-04991532 | 1215197-37-7 | 1215197-37-7 |
| Afatinib-d | 阿法替尼D6 | 1313874-96-2 |
| PF-4693627 | PF-4693627 | 1312815-93-2 |
| CU-CPT 4a | 化合物CU CPT 4A | 1279713-77-7 |
| MRT-81 | 化合物MRT-81 | 1263132-08-6 |
| SKI-178 | 化合物SKI-178 | 1259484-97-3 |
| BI-4394 | BI-4394 (BI4394) | 1222173-37-6 |
| 2-TEDC | (E)-2-(噻吩-2-基)乙基 2-氰基-3-(3,4-二羟基苯基)丙烯酸酯 | 132465-10-2 |
| C, | NUC-3373 | 1332837-31-6 |
| PERK-IN-2 | PERK-IN-2 | 1337531-83-5 |
| NF-κB-IN-1 | (1E,6E)-1,7-双(3,4-二甲氧基苯基)-4-(4-羟基-3-甲氧基亚苄基)庚-1,6-二烯-3,5-二酮 | 1227098-15-8 |
| 5,7-Dichlorokynurenic acid | 5,7-二氯犬尿喹啉酸 | 131123-76-7 |
| Saclofen | 3-氨基-2-(4-氯苯基-丙烷磺酸 | 125464-42-8 |
| Apixaban- | 阿哌沙班杂质13C-D3 | 1261393-15-0 |
| GNF179 | GNF179 | 1261114-01-5 |
| Carbamazepine-d | 1332295-35-8 | 1332295-35-8 |
| (1E)-CFI-400437 dihydrochloride | CS-2656 | 1247000-76-5 |
| Cilastatin- | (-)-土曲霉酸 | 121-40-4 |
| NMS-P515 | NMS-P515 | 1262395-13-0 |
| Lansoprazole sulfone | 兰索拉唑磺酸盐 | 131926-99-3 |
| SCD1 inhibitor-4 | 1H-Imidazole-4-carboxamide, 5-methyl-N-(1-methyl-1H-pyrazol-3-yl)-1-[[3-(trifluoromethyl)phenyl]methyl]- | 1295541-87-5 |
| Amsilarotene | 4-[[3,5-二(三甲基硅烷基)苯甲酰基]氨基]苯甲酸 | 125973-56-0 |
| DMU-212 | 3,4,5,4'-四甲氧基二苯乙烯 | 134029-62-2 |
| Febuxostat-d | 非布索坦 -D9 | 1246819-50-0 |
| Isavuconazole-d | 爱莎康唑-D4 | 1346598-58-0 |
| A-887826 | 5-(4-丁氧基-3-氯苯基)-N-[[2-(4-吗啉)-3-吡啶基]甲基]-3-吡啶甲酰胺 | 1266212-81-0 |
| JGB1741 | JGB1741 | 1256375-38-8 |
| RKI-1313 | 1-(3-METHOXYBENZYL)-3-(4-(PYRIDIN-4-YL)THIAZOL-2-YL)UREA | 1342276-76-9 |
| L-838417-d | CTP354 | 1213669-91-0 |
| Sofosbuvir impurity F | 索菲布韦杂质 | 1337482-17-3 |
| S2101 | 1239262-36-2 | 1239262-36-2 |
| DODAP | DODAP | 127512-29-2 |
| BBIQ | BBIQ | 1229024-57-0 |
| IMM-H007 | 化合物IMM-H007 | 1221412-23-2 |
| TC-N 1752 | TC-N 1752 | 1211866-85-1 |
| σ1 Receptor antagonist-1 | 化合物Σ1 RECEPTOR ANTAGONIST-1 | 1204401-49-9 |
| Moracin O | MORACIN O | 123702-97-6 |
| CIL56 | VATIQUINONE | 1213269-98-7 |
| CAIX Inhibitor S4 | CAIX Inhibitor S4 | 1330061-67-0 |
| PF-04449613 | FHBANDDJQJAZOQ-CQSZACIVSA-N | 1236858-52-8 |
| DDD85646 | DDD85646 | 1215010-55-1 |
| Quilseconazole | Quilseconazole | 1340593-70-5 |
| RU-TRAAK-2 | 化合物RU-TRAAK-2 | 1210538-56-9 |
| Modoflaner | 化合物MODOFLANER | 1331922-53-2 |
| CDC25B-IN-2 | 化合物BIA | 134271-74-2 |
| BI 99179 | BI-99179 | 1291779-76-4 |
| Alphitolic acid | 尼罗替尼-D6 | 1268356-17-7 |
| Izilendustat | 1303512-02-8 | 1303512-02-8 |
| Sulfosuccinimidyl oleate sodium | 磺基琥珀酰油酸酯(钠盐) | 1212012-37-7 |
| CGP35348 | (3-氨丙基)(二乙氧基甲基)膦酸水合物 | 123690-79-9 |
| DBPR112 | DBPR112 | 1226549-49-0 |
| (Rac)-Apremilast-d | 阿普斯特D5 (RACEMIC) | 1258597-61-3 |
| DPQ | DMEM低糖 | 129075-73-6 |
| Aminoglutethimide | 氨鲁米特 | 125-84-8 |
| Acamprosate-d | ACAMPROSATE-D3 CALCIUM | 1225580-94-8 |
| 5α-Hydroxycostic acid | 5Α-HYDROXYCOSTIC ACID | 132185-83-2 |
| Apremilast-d | 阿普斯特-D5 | 1258597-47-5 |
| IPI-9119 | IPI-9119 | 1346564-56-4 |
| TASP0415914 | CS-2671 | 1292300-75-4 |
| Thalidomide-d | 沙利度胺-D4 | 1219177-18-0 |
| Tolnaftate-d | FUSNMLFNXJSCDI-BTSZWIDXSA-N | 1329835-64-4 |
| TK05 | TK05 | 1245734-61-5 |
| Ivabradine metabolite N-Demethyl Ivabradine hydrochloride | N-去甲盐酸伊伐布雷定 | 1246638-08-3 |
| Dapagliflozin-d | 达格列净-D5 | 1204219-80-6 |
| CP-31398 dihydrochloride | CP-31398 DIHYDROCHLORIDE HYDRATE | 1217195-61-3 |
| TAI-1 | TAI-1 | 1334921-03-7 |
| Icosabutate | 1253909-57-7 | 1253909-57-7 |
| BACE1-IN-1 | 1310347-50-2 | 1310347-50-2 |
| GNE-0439 | GNE0439 | 1241902-40-8 |
| 1-Hydroxyanthraquinone | 1-羟基蒽醌 | 129-43-1 |
| Evolocumab | 依洛尤单抗 | 1256937-27-5 |
| SR1664 | 4′-[[2,3-Dimethyl-5-[[[(1S)-1-(4-nitrophenyl)ethyl]amino]carbonyl]-1H-indol-1-yl]methyl]- [1,1′-Biphenyl]-2-carboxylic acid | 1338259-05-4 |
| MMV390048 | 化合物MMV390048 | 1314883-11-8 |
| MR837 | 4-氰基-N-环丙基-N-(噻吩-2-基甲基)苯甲酰胺 | 1210906-48-1 |
| IL-4-inhibitor-1 | IL-4 INHIBITOR | 1332184-63-0 |
| Aureobasidin A | 巴西芬净 | 127785-64-2 |
| (rac)-(trans)-Paroxetine-d | 决奈达隆-d6盐酸盐 | 1329809-23-5 |
| Vitamin K1-d7 | Vitamin K1-d7 | 1233937-39-7 |
| Eberconazole nitrate | 硝酸依柏康唑 | 130104-32-4 |
| PF9601N | PF 9601N | 133845-63-3 |
| ON1231320 | CS-2589 | 1312471-39-8 |
| Samatasvir | ATOLIHZIXHZSBA-BTSKBWHGSA-N | 1312547-19-5 |
| 4'-Bromo-resveratrol | 5-[(E)-2-(4-溴苯基)乙烯基]间苯二酚 | 1224713-90-9 |
| Ibezapolstat | ACX-362E | 1275582-97-2 |
| PS210 | PS 210 | 1221962-86-2 |
| Acetic acid potassium 99% | 乙酸钾 | 127-08-2 |
| FIDAS-3 | FIDAS-3 | 1266684-01-8 |
| C12-200 | C12-200 | 1220890-25-4 |
| Pagoclone | 帕戈隆 | 133737-32-3 |
| Indophagolin | 5-溴-N-(4-氯-3-(三氟甲基)苯基)-1-(环丙烷羰基)吲哚啉-6-磺酰胺 | 1207660-00-1 |
| SCD1 inhibitor-3 | 化合物SCD1 INHIBITOR-3 | 1282606-48-7 |
| FPL64176 | 2,5-DIMETHYL-4-[2-(PHENYLMETHYL)BENZOYL]-1H-PYRROLE-3-CARBOXYLIC ACID METHYL ESTER | 120934-96-5 |
| Icenticaftor | 3-氨基-6-甲氧基-N-[(2S)-3,3,3-三氟-2-羟基-2-甲基丙基]-5-(三氟甲基)-2-吡啶甲酰胺 | 1334546-77-8 |
| Brilacidin | 1224095-98-0 | 1224095-98-0 |
| Lutein | 叶黄素 | 127-40-2 |
| JTE-952 | JTE 952) | 1255303-54-8 |
| Mebeverine hydrochloride | PF-05198007 | 1235406-19-5 |
| Chiauranib | 1-Naphthalenecarboxamide, N-(2-aminophenyl)-6-[(7-methoxy-4-quinolinyl)oxy]- | 1256349-48-0 |
联系方式
